|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/46 | (2006.01) |
| A61P 1/16 | (2006.01) | ||
| A61P 3/00 | (2006.01) |
| (11) | Patento numeris | 3518962 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17791485.0 |
| Europos patento paraiškos padavimo data | 2017-09-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-08-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-06-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/053961 |
| Data | 2017-09-28 |
| (87) | Numeris | WO 2018/064303 |
| Data | 2018-04-05 |
| (30) | Numeris | Data | Šalis |
| 201662402183 P | 2016-09-30 | US | |
| 201662420233 P | 2016-11-10 | US | |
| 201762456511 P | 2017-02-08 | US |
| (72) |
QUINN, Anthony , US
GOODMAN, Zachary , US
BURTON, Barbara , US
RANKIN, Andrew , US
FRIEDMAN, Mark , US
SONI, Paresh , US
|
| (73) |
Alexion Pharmaceuticals, Inc. ,
121 Seaport Boulevard, Boston, MA 02210,
US
|
| (54) | SEBELIPASE ALFA FOR USE IN LIVER FIBROSIS AND TREATING LYSOSOMAL ACID LIPASE DEFICIENCY IN PATIENTS BASED ON ISHAK FIBROSIS STAGE |
| SEBELIPASE ALFA FOR USE IN LIVER FIBROSIS AND TREATING LYSOSOMAL ACID LIPASE DEFICIENCY IN PATIENTS BASED ON ISHAK FIBROSIS STAGE |